Cihangir Akyol, MD, FACS, FASCRS, FEBS-C (@cihangirakyol) 's Twitter Profile
Cihangir Akyol, MD, FACS, FASCRS, FEBS-C

@cihangirakyol

Professor of Surgery at Ankara University- EBSQ Certified Colorectal Surgeon - Colorectal Cancer and Surgical Education. Tweets in Turkish & English.

ID: 187106534

linkhttp://cihangirakyol.com calendar_today05-09-2010 08:09:14

9,9K Tweet

5,5K Followers

4,4K Following

TKRCD (@tkrcd_) 's Twitter Profile Photo

🎓You’re Invited to the EBSQ Coloproctology Certification Preparation Course! 🗓 Thuesday, July 1, 2025 ⏰ 21:00-22:00 (GMT+3) 👨‍⚕Presenter: Frederic Ris, MD Topic: Colonic Diverticular Disease: Evidence-Based Management #ebsq #escp #coloproctology #TSCRS

🎓You’re Invited to the EBSQ Coloproctology Certification Preparation Course!

🗓 Thuesday, July 1, 2025
⏰ 21:00-22:00 (GMT+3)
👨‍⚕Presenter: Frederic Ris, MD

Topic: Colonic Diverticular Disease: Evidence-Based Management

#ebsq #escp #coloproctology #TSCRS
TKRCD (@tkrcd_) 's Twitter Profile Photo

🎓TKRCD Yeterlik Değerlendirme ve EBSQ Koloproktoloji Hazırlık Kursuna Davetlisiniz! 🗓 2 Temmuz 2025, Çarşamba ⏰ 21:00-22:00 (GMT+3) 👨‍⚕Konuşmacı: Dr. Murat Çakır Konu: Fekal İnkontinens #ebsq #koloproktoloji #TKRCD #KoloproktolojiEgitimi #TKRCDyeterlikdegerlendirme

🎓TKRCD Yeterlik Değerlendirme ve EBSQ Koloproktoloji Hazırlık Kursuna Davetlisiniz!

🗓 2 Temmuz 2025, Çarşamba
⏰ 21:00-22:00 (GMT+3)
👨‍⚕Konuşmacı: Dr. Murat Çakır

Konu: Fekal İnkontinens

#ebsq #koloproktoloji #TKRCD #KoloproktolojiEgitimi #TKRCDyeterlikdegerlendirme
TKRCD (@tkrcd_) 's Twitter Profile Photo

Dikkat 🚨 Sanal akademiden kritik konu uyarısı❗ Divertikülozisli hastada tekrarlayan karın ağrısının arkasında gerçekten inflamasyon mu var? Komplike divertikülit yönetimindeki “gri alanları” netleştirme çabasında; mevcut sınıflandırma sistemleri klinik karar süreçlerini

BJS (@bjsurgery) 's Twitter Profile Photo

Follow Our Peritoneal Malignancy Weekend! 🚨 From international consensus to surgical boundaries and the latest advances in cytoreductive surgery for peritoneal surface malignancies #2⃣ Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus

Follow Our Peritoneal Malignancy Weekend! 🚨
From international consensus to surgical boundaries and the latest advances in cytoreductive surgery for peritoneal surface malignancies

#2⃣ Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus
Cihangir Akyol, MD, FACS, FASCRS, FEBS-C (@cihangirakyol) 's Twitter Profile Photo

How well does Goodsall’s Rule hold up to modern imaging? We revisited this surgical classic with MRI in 305 fistula cases. The result: ~49% accuracy overall. Anterior fistulas predict better; posterior less so. MRI is essential. turkishjcrd.com/pdf/b0c0ce94-e… Excellent retrospective

TKRCD (@tkrcd_) 's Twitter Profile Photo

Laparoscopic Versus Open Complete Mesocolic Excision with Central Vascular Ligation for Right-sided Colon Cancer: Early Postoperative Outcomes You can see the free full text of the research by Azmi Lale et al. Turk J Colorectal Dis 2022;32(3):194-201 DOI:

Laparoscopic Versus Open Complete Mesocolic Excision with Central Vascular Ligation for Right-sided Colon Cancer: Early Postoperative Outcomes

You can see the free full text of the research by Azmi Lale et al.
Turk J Colorectal Dis 2022;32(3):194-201  DOI:
Sezai Leventoglu (@sezaileventoglu) 's Twitter Profile Photo

New study alert! Not all long anal fistulas obey Goodsall’s rule. Our case series shows that fistulas >7.5 cm—often anterior, intersphincteric or low transsphincteric—can be simple, not complex. 🚫 Length ≠ complexity 🧠 Surgical insight from real-world data TKRCD

Mario Balsa (@mariobalsamd) 's Twitter Profile Photo

🧪 Blood-based tests are shaking up CRC screening! #ESMOGI25 🔬 cfDNA (SHIELD, FREEDOME): sensitivity 83–91.5% 🧻 ColoSense™: 94% CRC sensitivity, FDA approved 📈 Real-world impact driven by better adherence 🧠 From FIT to futuristic—CRC screening is getting a liquid upgrade!

🧪 Blood-based tests are shaking up CRC screening! #ESMOGI25 

🔬 cfDNA (SHIELD, FREEDOME): sensitivity 83–91.5%
🧻 ColoSense™: 94% CRC sensitivity, FDA approved
📈 Real-world impact driven by better adherence

🧠 From FIT to futuristic—CRC screening is getting a liquid upgrade!
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

Sizce onkolojideki en büyük sorun ne? Sorduk. Cevaplar düşündürücüydü. Geç tanı ve doktora ulaşmak en çok belirtilen sorun. Tedaviye erişim ve maliyet onu takip ediyor. Yanlış bilgi ve yan etkiler de sıkça dile getirilen diğer problemler. Ama sadece bunlarla sınırlı değildi.

Sizce onkolojideki en büyük sorun ne?
Sorduk. Cevaplar düşündürücüydü.

Geç tanı ve doktora ulaşmak en çok belirtilen sorun.
Tedaviye erişim ve maliyet onu takip ediyor.
Yanlış bilgi ve yan etkiler de sıkça dile getirilen diğer problemler.

Ama sadece bunlarla sınırlı değildi.
TKRCD (@tkrcd_) 's Twitter Profile Photo

🎓You’re Invited to the TBCRS-Q and EBSQ Coloproctology Certification Preparation Course! 🗓 Wednesday, July 9, 2025 ⏰ 21:00-22:00 (GMT+3) 👨‍⚕Presenter: Volkan Doğru, MD Topic: AIN & Anal Cancer #ebsq #coloproctology #TSCRS #ColoproctologyEducation #TSCRSProficiency

🎓You’re Invited to the TBCRS-Q and EBSQ Coloproctology Certification Preparation Course!

🗓 Wednesday, July 9, 2025
⏰ 21:00-22:00 (GMT+3)
👨‍⚕Presenter: Volkan Doğru, MD

Topic: AIN & Anal Cancer

#ebsq #coloproctology #TSCRS #ColoproctologyEducation #TSCRSProficiency
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

Robotic surgery outperformed laparoscopy for rectal cancer. 3-year local recurrence: 1.6% vs 4% Better disease-free survival (87% vs 83%) Improved urinary, sexual, and bowel function No major OS difference JAMA OncoAlert Oncology Brothers jamanetwork.com/journals/jama/…

Robotic surgery outperformed laparoscopy for rectal cancer.
3-year local recurrence: 1.6% vs 4%
Better disease-free survival (87% vs 83%)
Improved urinary, sexual, and bowel function
No major OS difference
<a href="/JAMA_current/">JAMA</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/OncBrothers/">Oncology Brothers</a> 
jamanetwork.com/journals/jama/…